<DOC>
	<DOCNO>NCT02183116</DOCNO>
	<brief_summary>To Access Efficacy Safety Meloxicam 7.5mg daily treatment period 56 day</brief_summary>
	<brief_title>A Study Access Efficacy Safety Meloxicam Patients With Osteoarthritis Knee</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Meloxicam</mesh_term>
	<criteria>Osteoarthritis knee require therapy nonsteroidal antiinflammatory drug ( NSAIDs )</criteria>
	<gender>All</gender>
	<minimum_age>34 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>